FastForward Innovations Ltd (LON:FFWD) said it has invested A$1mln in a placing undertaken by Little Green Pharma Ltd (ASX:LGP), a medicinal cannabis business that supplies the Australian and overseas markets. In a separate announcement late on Thursday afternoon, FFWD said another company in its portfolio, Portage Biotech Inc, has announced its research and development goals for 2021.
Mode Global Holdings PLC (LON:MODE) said it has officially launched the Android version of its popular financial app as it revealed Bitcoin trading volumes on the platform had increased by 130% month on month.
Cornish Lithium Ltd has started its second drilling campaign at its Trelavour hard rock lithium project near St Austell, with two drill rigs expected to be on-site for eight to ten weeks.
Faron Pharma PLC (LON:FARN) has raised EUR15mln from an accelerated share placing that will be used to fund its work in the clinic.
Kromek PLC (LON:KMK) is to raise up to GBP13mln through a firm placing, directors’ subscription and open offer, with the money said to be earmarked for its range of bio-security/pathogen detectors and to increase the rate of commercialisation of its nuclear detection and medical imaging ranges.
Applied Graphene Materials PLC (LON:AGM) confirmed that at the general meeting held today, shareholders approved the issue of the second placing shares, subscription shares and PrimaryBid shares. Accordingly, the speciality graphene producer has raised a total of GBP6mln.
Bezant Resources PLC (LON:BZT), the copper-gold exploration and development company, said the acquisition of Metrock Resources, announced last month, has now completed. The company also announced that the application for the exclusive prospecting licence (EPL) 7170 has been successful.
Zephyr Energy Plc (LON:ZPHR) has revealed some details of analysis of the Paradox project, following the initial findings of the State 16-2 well.
MGC Pharmaceuticals Ltd (LON:MXC, ASX:MXC), as the first and currently only medicinal cannabis company to be listed on the London Stock Exchange, presented at an investor webinar at 10am today. Chief executive Roby Zomer and executive chairman Brett Mitchell presented and answered questions from attendees.
Oriole Resources PLC (LON:ORR) said 16.875mln new ordinary shares will be issued following an exercise of warrants. They will be admitted to trading on AIM on February 17, 2021, with an exercise price 0.68p apiece.
Landore Resources Limited (LON:LND) announced that it has received a notice to exercise warrants over a total of 500,000 ordinary shares, for which the company has recieved funds of GBP100,000.
Remote Monitored Systems plc (LON:RMS) provided details for shareholders wishing to view today’s general meeting at 1pm, as shareholders have not been permitted to attend due to government coronavirus restrictions. Shareholders wishing to follow it online have been provided a Zoom link, but the company said will be no opportunity to ask questions and voting on the resolutions today will be by poll.
Tower Resources PLC (LON:TRP) announced that it has updated its website to reflect the latest information regarding its 50% share in the Algoa-Gamtoos license in South Africa, as mentioned in its announcement on February 8. The website update contains additional information and diagrams which could not be included in the earlier RNS, the company said.
Evgen Pharma PLC (LON:EVG) announced that it is posting a circular to shareholders in relation to its proposed fundraising, including the notice of its general meeting, a proxy voting form and an open offer application form. The meeting will be held at 10am on March 3. No shareholders other than the minimum number of board members will be able to attend and so shareholders are requested to complete the form of proxy by the relevant time.
Ariana Resources PLC (LON:AAU) has today published a Q&A document on its website in relation to the circular that was posted to shareholders on February 8, 2021. The Q&A document clarifies certain points concerning the proposed reduction of share capital via cancellation of the company’s share premium account, the cancellation of the deferred shares and the authority for the company to buy back shares.